Remove 2020 Remove Article Remove Pharmaceutical Companies Remove Process Improvement
article thumbnail

An Evaluation of Postapproval CMC Change Timelines

ISPE

These long global approval timelines complicate supply chain management by delaying innovations that improve quality assurance and by increasing the potential for supply interruptions and shortages that impact patient access to products. Scope The scope of the assessment was for country approvals received in the calendar years 2018–2020.